Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marc Limacher

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Expert Review of Vaccines|August 25, 2005
MUC1 as a target antigen for cancer immunotherapyBruce Acres, Jean-Marc Limacher
Bulletin Du Cancer|March 21, 2007
[MUC1, a therapeutic target in oncology]Jean-Marc Limacher, Bruce Acres
Oncoimmunology|August 31, 2012
TG4010: A therapeutic vaccine against MUC1 expressing tumorsJean-Marc Limacher, Elisabeth Quoix
Current Opinion in Drug Discovery & Development|April 18, 2007
Discovery and development of therapeutic cancer vaccinesBruce Acres, Jean-Marc Limacher, Jeanoy Bonnefoy
Current Topics in Microbiology and Immunology|February 23, 2015
Targeted Immunotherapy Designed to Treat MUC1-Expressing Solid TumourBruce Acres, Gisele Lacoste, Jean-Marc Limacher
Case Reports in Oncological Medicine|May 21, 2025
Case Report: Fatal <i>Pneumocystis jirovecii</i> Infection in an Elderly Man Receiving Adjuvant Paclitaxel and Trastuzumab Therapy for HER2-Positive Breast CancerColin Vercueil, Hamza Ouaz, Emilie Schultz, et al.
Human Vaccines & Immunotherapeutics|August 17, 2012
Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccinesHouda Boukhebza, Nadine Bellon, Jean Marc Limacher, et al.
Idrugs : the Investigational Drugs Journal|May 10, 2007
Cancer vaccines: challenges and outlook in the fieldStéphane Paul, Bruce Acres, Jean-Marc Limacher, et al.
Expert Review of Vaccines|March 19, 2013
Therapeutic cancer vaccines in the treatment of non-small-cell lung cancerJean-Marc Limacher, Clémentine Spring-Giusti, Nadine Bellon, et al.
Plos One|July 25, 2015
Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical TrialChristine Rotonda, Amélie Anota, Mariette Mercier, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Expert Review of Vaccines|August 25, 2005
MUC1 as a target antigen for cancer immunotherapyBruce Acres, Jean-Marc Limacher
Bulletin Du Cancer|March 21, 2007
[MUC1, a therapeutic target in oncology]Jean-Marc Limacher, Bruce Acres
Oncoimmunology|August 31, 2012
TG4010: A therapeutic vaccine against MUC1 expressing tumorsJean-Marc Limacher, Elisabeth Quoix
Current Opinion in Drug Discovery & Development|April 18, 2007
Discovery and development of therapeutic cancer vaccinesBruce Acres, Jean-Marc Limacher, Jeanoy Bonnefoy
Current Topics in Microbiology and Immunology|February 23, 2015
Targeted Immunotherapy Designed to Treat MUC1-Expressing Solid TumourBruce Acres, Gisele Lacoste, Jean-Marc Limacher
Case Reports in Oncological Medicine|May 21, 2025
Case Report: Fatal <i>Pneumocystis jirovecii</i> Infection in an Elderly Man Receiving Adjuvant Paclitaxel and Trastuzumab Therapy for HER2-Positive Breast CancerColin Vercueil, Hamza Ouaz, Emilie Schultz, et al.
Human Vaccines & Immunotherapeutics|August 17, 2012
Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccinesHouda Boukhebza, Nadine Bellon, Jean Marc Limacher, et al.
Idrugs : the Investigational Drugs Journal|May 10, 2007
Cancer vaccines: challenges and outlook in the fieldStéphane Paul, Bruce Acres, Jean-Marc Limacher, et al.
Expert Review of Vaccines|March 19, 2013
Therapeutic cancer vaccines in the treatment of non-small-cell lung cancerJean-Marc Limacher, Clémentine Spring-Giusti, Nadine Bellon, et al.
Plos One|July 25, 2015
Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical TrialChristine Rotonda, Amélie Anota, Mariette Mercier, et al.
Pageof 5